{"result": "(\"entity\"<|>DISFAGIA OROFARÍNGEA<|>EVENT<|>Disfagia orofaríngea is a condition characterized by difficulty in swallowing, often requiring multidisciplinary solutions for rehabilitation.)\n##\n(\"entity\"<|>ELECTROESTIMULACIÓN NEUROMUSCULAR DE SUPERFICIE<|>EVENT<|>Electroestimulación neuromuscular de superficie is a therapeutic technique involving electrical stimulation of muscles to enhance function or prevent atrophy.)\n##\n(\"entity\"<|>QUIMIORADIOTERAPIA<|>EVENT<|>Quimioradioterapia is a treatment method combining chemotherapy and radiation therapy, often used for patients with head and neck cancer.)\n##\n(\"entity\"<|>MÚSCULOS SUPRAHIOIDEOS<|>ORGANIZATION<|>Los músculos suprahioideos are a group of muscles that play a crucial role in swallowing and airway protection.)\n##\n(\"entity\"<|>MÚSCULOS INTRÍNSECOS LARÍNGEOS<|>ORGANIZATION<|>Los músculos intrínsecos laríngeos are responsible for controlling the vocal cords and are essential for airway protection during swallowing.)\n##\n(\"relationship\"<|>DISFAGIA OROFARÍNGEA<|>ELECTROESTIMULACIÓN NEUROMUSCULAR DE SUPERFICIE<|>Electroestimulación neuromuscular de superficie is used as a treatment for patients suffering from disfagia orofaríngea<|>8)\n##\n(\"relationship\"<|>QUIMIORADIOTERAPIA<|>CANCER OF HEAD AND NECK<|>Quimioradioterapia is a common treatment for patients diagnosed with cancer of the head and neck<|>9)\n##\n(\"relationship\"<|>MÚSCULOS SUPRAHIOIDEOS<|>DISFAGIA OROFARÍNGEA<|>The suprahyoid muscles are involved in the swallowing process, which is affected in patients with disfagia orofaríngea<|>7)\n##\n(\"relationship\"<|>MÚSCULOS INTRÍNSECOS LARÍNGEOS<|>DISFAGIA OROFARÍNGEA<|>The intrinsic laryngeal muscles are crucial for airway protection during swallowing, which is compromised in disfagia orofaríngea<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: la semana durante\n                  4-5 semanas. El EMST aumenta la duración y amplitud de la activación de los\n                  músculos suprahioideos dando lugar a un aumento del movimiento del hioi-\n                  des25. Disminuyen el riesgo de penetración-aspiración en pacientes con enfer-\n\n                  medad de Parkinson y tras ictus40,41.\n\n\n\n172\n---\n                                                                        7. Rehabilitación de la disfagia orofaríngea\n\n\n\n     3.2.4. Ejercicios vocales y de cierre glótico\n         El cierre glótico junto con la elevación laríngea son los dos mecanismos principa-\n     les de defensa de la vía aérea. Las parálisis en las cuerdas vocales o la atrofia de los\n     músculos intrínsecos laríngeos relacionados con la edad ocasionan un cierre glótico\n     insuficiente aumentando el riesgo de aspiración y desarrollo de neumonía. Por ello\n     en estos pacientes se incluyen ejercicios vocales de cierre glótico42 .\n         Los ensayos clínicos de Peng et al35 y Ohba et al 38 , han observado que las técnicas\n     o ejercicios activos pueden tener también un papel preventivo en pacientes con cán-\n     cer de cabeza y cuello. Antes o durante el tratamiento con quimiorradioterapia los\n     pacientes realizan programas de ejercicios que incluyen de forma variable ejercicios\n     de cuerdas vocales, presión de la lengua, deglución fuerte, estiramiento de apertura\n     mandibular o ejercicios de Shaker. Estos pacientes mostraron un menor deterioro de\n     la función deglutoria y de la actividad muscular, una mejora en la dieta y el estado\n     nutricional, y menos complicaciones relacionadas con la DOF. No obstante, sigue\n     siendo objeto de debate el alcance de estos tratamientos y el momento idóneo\n     para iniciarlos.\n\n\n\n        4.   ELECTROESTIMULACIÓN NEUROMUSCULAR\n             DE SUPERFICIE\n\n\n\n         Consiste en la aplicación de un estímulo eléctrico a los músculos de la región\n     supra- e infrahioidea a través de electrodos colocados sobre la piel en la cara anterior\n     del cuello para producir una potenciación muscular o prevenir la atrofia por desuso.\n         Los resultados de los primeros trabajos con electroestimulación de superficie\n     fueron contradictorios y controvertidos, con algunos datos sobre el potencial riesgo\n     de descenso laríngeo en función de los parámetros y los dispositivos de aplicación.\n         En el año 2001, la Food and Drug Administration (FDA) de Estados Unidos aprobó\n     un dispositivo de electroestimulación, el VitalStim® (Chattanooga Group) que no pro-\n     ducía los efectos paradójicos indeseables de descenso de la laringe. Se ha estudiado\n     la eficacia y seguridad del VitalStim® en diversas patologías, si bien los estudios más\n     numerosos han sido en el ictus43-47 . La electroestimulación obtiene resultados seme-\n     jantes a la terapia tradicional, pero combinada con ella los resultados son mejores.\n     Bahtt et al48 la emplean como adyuvante a los tratamientos preventivos previos a la\n     quimiorradioterapia, o durante la misma, en pacientes con cáncer de cabeza y cuello\n     obteniendo mejores parámetros en la función deglutoria.\n\n\n\n173\n---\n MANUAL DE DISFAGIA OROFARÍNGEA: SOLUCIONES MULTIDISCIPLINARES\n\n\n\n             Los protocolos de tratamiento utilizan diferentes localizaciones para los electro-\n         dos y se combina con distintas maniobras deglutorias. Los tiempos de estimulación\n         oscilan entre los 30 minutos a 1 hora por sesión, de 3 a 5 sesiones por semana y una\n         duración entre 2 y 12 semanas.\n             Por sus efectos adversos (arritmia, laringoespasmo, cierre glótico, quemaduras o\n         hipotensión) relacionados con una incorrecta colocación de los electrodos o el uso\n         de los parámetros de la corriente eléctrica, debe utilizarse por profesionales formados\n         y certificados para la utilización del dispositivo. No puede emplearse en pacientes\n         portadores de marcapasos o portadores de dispositivos de estimulación cerebral\n         profunda o de estimulación de cordones posteriores. Tampoco puede utilizarse sobre\n         músculo denervado, en disfagia secundaria a toxicidad farmacológica o en pacientes\n         con tumor activo sobre la zona orofaríngea o epilepsia.\n             El paciente ha de colaborar durante el tratamiento, realizando una deglución\n         activa (con o sin un bolo seguro) al percibir el estímulo eléctrico. No está indicado en\n         pacientes con demencia o psicopatología con verbalización constante.\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>EMST<|>ORGANIZATION<|>EMST is a therapeutic approach that enhances the activation of suprahyoid muscles, reducing the risk of aspiration in patients with Parkinson's disease and post-stroke conditions.)\n##\n(\"entity\"<|>PENG ET AL<|>PERSON<|>Peng et al are researchers who conducted clinical trials observing the effects of vocal exercises in patients with head and neck cancer.)\n##\n(\"entity\"<|>OHBA ET AL<|>PERSON<|>Ohba et al are researchers who studied the role of active techniques in preventing complications in patients undergoing treatment for head and neck cancer.)\n##\n(\"entity\"<|>FDA<|>ORGANIZATION<|>The Food and Drug Administration (FDA) is a U.S. government agency that approved the VitalStim device for neuromuscular electrical stimulation.)\n##\n(\"entity\"<|>VITALSTIM<|>ORGANIZATION<|>VitalStim is a device approved by the FDA for neuromuscular electrical stimulation, used to enhance muscle function in patients with swallowing difficulties.)\n##\n(\"entity\"<|>CHATTANOOGA GROUP<|>ORGANIZATION<|>Chattanooga Group is the manufacturer of the VitalStim device, which is used for neuromuscular electrical stimulation.)\n##\n(\"entity\"<|>CANCER OF HEAD AND NECK<|>EVENT<|>Cancer of the head and neck is a medical condition that may require interventions such as vocal exercises and neuromuscular electrical stimulation.)\n##\n(\"relationship\"<|>PENG ET AL<|>CANCER OF HEAD AND NECK<|>Peng et al's research focused on the effects of vocal exercises in patients with head and neck cancer<|>7)\n##\n(\"relationship\"<|>OHBA ET AL<|>CANCER OF HEAD AND NECK<|>Ohba et al's studies examined the preventive role of exercises in patients with head and neck cancer<|>7)\n##\n(\"relationship\"<|>VITALSTIM<|>FDA<|>The FDA approved the VitalStim device for use in neuromuscular electrical stimulation<|>9)\n##\n(\"relationship\"<|>VITALSTIM<|>CHATTANOOGA GROUP<|>VitalStim is manufactured by Chattanooga Group, which produces devices for therapeutic use<|>8)\n##\n(\"relationship\"<|>EMST<|>CANCER OF HEAD AND NECK<|>EMST techniques are used to improve swallowing function in patients with head and neck cancer<|>6)\n<|COMPLETE|>"}]}